[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147-149.[doi:10.3969/j.issn.1006-1959.2018.05.053]
　DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Journal of Medical Information,2018,31(05):147-149.[doi:10.3969/j.issn.1006-1959.2018.05.053]
点击复制

SPECT/CT 双时相99mTc- MIBI断层显像 在乳腺癌诊断中的应用()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年05期
页码:
147-149
栏目:
诊疗技术
出版日期:
2018-03-01

文章信息/Info

Title:
Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer
文章编号:
1006-1959（2018）05-0147-03
作者:
董 云
广西柳州市中医院核医学科，广西 柳州 545001
Author(s):
DONG Yun
Department of Nuclear Medicine,Liuzhou Chinese Medicine Hospital,Liuzhou 545001,Guangxi,China
关键词:
乳腺癌; SPECT/CT; 99mTc-MIBI断层显像; 钼靶 X 线
Keywords:
Key words：Breast cancer; SPECT/CT; 99mTc-MIBI tomography; Molybdenum target X-ray
分类号:
R817.4
DOI:
10.3969/j.issn.1006-1959.2018.05.053
文献标志码:
A
摘要:
目的 探讨SPECT/CT双时相 99mTc-MIBI断层显像在乳腺癌临床中的诊断价值。 方法 选取2015 年 1 月~2017 年 5月广西柳州市中医院胸外科收治的女性乳腺疾病患者 98 例进行了术前两种检查方法的诊断，并将诊断结果记录，与术后的病理结果进行比对。结果 SPECT/CT双时相 99mTc-MIBI断层显像的敏感性94.80%、特异性90.00%、准确性93.90%，高于钼靶 X 线检查的敏感性82.10%、特异性60.00%、准确性77.60%，SPECT/CT双时相 99mTc-MIBI断层显像和钼靶 X 线检查对腋窝淋巴结转移灶的检出率分别为84.30%和59.40%，两种检查方法对乳腺癌的诊断比较均有统计学差异（P＜0.05）。 结论 99mTc- MIBI双时相断层显像对乳腺癌的诊断效能优于钼靶X线检查，有较高的实用价值。
Abstract:
Abstract：Objective To evaluate the diagnostic value of SPECT/CT dual-phase 99mTc-MIBI tomography in breast cancer.Methods A total of 98 women with breast diseases admitted in Department of thoracic surgery,Liuzhou Hospital of traditional Chinese medicine in January 2015~2017 May,were selected for the diagnosis of two kinds of examination methods before operation,and the diagnosis results were compared with postoperative pathological results.The results of the two diagnostic methods were compared.Results SPECT/CT 99mTc-MIBI double phase imaging sensitivity of 94.80%,specificity of 90.00%,accuracy of 93.90%,higher than mammography sensitivity 82.10%,specificity 60.00%,accuracy 77.60%,SPECT/CT 99mTc-MIBI double phase imaging and mammography node metastasis detection rates were 84.30% and 59.40% of axillary lymph,two methods in diagnosis of breast cancer were statistically significant(P<0.05).Conclusion 99mTc- MIBI double phase tomography is superior to mammography in diagnosis of breast cancer, and has high practical value.

参考文献/References:

[1]李树龄,主编.乳腺肿瘤学[M].北京:北京科学技术文献出版社,2000:3. [2]杨学伟,杨维良,王秀兰,等.99mTc- MIBI乳腺显像与乳腺X线照相在乳腺癌诊断中的价值[J].中国普通外科杂志,2004,13 (11): 801-803. [3]曹芹.钼钯 X 线与彩超对乳腺癌诊断价值的对比研究[J].中国医学工程,2014,22(6):48. [4]贾莉,邹天宁,夏正武,等.99mTc- MIBI乳腺显像评价乳腺癌新辅助化疗效果的临床价值[J].现代医学,2014,42（1）4-8. [5]文美玲,梁庆模,包铮,等.低剂量99mTc-MIBI乳腺断层双时相显像诊断乳腺癌的临床研究[J].中国肿瘤临床,2013(1):36-40. [6]赵小艳,文美玲,梁庆模,等.半剂量99mTc-MIBI双时相断层显像在乳腺肿块诊断中的价值[J].山东医药,2013,53(26):9-11. [7]贾晓娟, 姜仁伟, 杨胜利,等.99mTc-MIBI在乳腺良恶性包块鉴别中的应用价值[J]. 中国医学创新, 2013(17):84-86. [8]张楠,李春林,邹兰芳,等.99mTc-MIBI乳腺显像与乳腺钼靶X线照相在乳腺癌诊断中的应用[J].中国临床医学影像杂志,2008,19(12):872-875. [9]Kim S J,Bae Y T,Lee J S,et al.Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings:visual and quantitative analyses[J].Annals of Nuclear Medicine,2007,21(3):145-150. [10]Mathieu I,Mazy S,Willemart,et al.Inconclusive triple diagno-sis in breast cancer imaging:is there a place for scintimammog-raphy[J].J Nucl Med,2005(46):1571- 1573. [11]Myslivecek M,Koranda P,Kamínek M,et al.Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement[J].Nuclear medicine review.Central&Eastern Europe: journal of Bulgarian,Czech,Macedonian,Polish,Romanian,Russian,Slovak,Yugoslav societies of nuclear medicine and Ukrainian Society of Radiology,2004,7(2):151-155. [12]伍瑛,肖萤.高频超声和X线钼靶联合诊断小乳腺癌的临床研究[J].医学临床研究,2004, 21(10):1139-1142. [13]Usmani S,Niaz K,MaseehUzZaman,et al.Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer[J].Jpma the Journal of the Pakistan Medical Association,2007,57(4):172-175.

相似文献/References:

[1]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
　ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Journal of Medical Information,2022,35(05):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[2]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[3]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
　YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Journal of Medical Information,2018,31(05):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[4]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
　LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Journal of Medical Information,2022,35(05):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[5]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
　LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Journal of Medical Information,2019,32(05):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[6]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
　MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Journal of Medical Information,2019,32(05):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[7]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与 健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
　LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Journal of Medical Information,2018,31(05):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[8]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
　MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Journal of Medical Information,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[9]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
　ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(05):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
[10]苏 晓.乳腺癌的靶向药物治疗[J].医学信息,2019,32(12):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]
　SU Xiao.Targeted Drug Therapy for Breast Cancer[J].Journal of Medical Information,2019,32(05):46.[doi:10.3969/j.issn.1006-1959.2019.12.015]

更新日期/Last Update: 2018-03-01